IPO Trending
SOTACSME / NSEListed

Sotac Pharmaceuticals Limited

Incorporated in 2015, Sotac Pharmaceuticals Limited, part of the Gujarat-based SOTAC Group, is engaged in manufacturing pharmaceutical products for various marketers on a loan license and contract manufacturing basis. Serving over 162 corporate clients, the company operates primarily on a principal-to-principal model. Established in 2017, its manufacturing facility has an annual capacity of 90 crore tablets and 14 crore capsules. Backed by promoters with over 59 years of combined industry experience, Sotac Pharmaceuticals continues to expand and strengthen its presence in the pharmaceutical sector.

₹105 - ₹1111.6x sub
Listed Price115.00
Listing Gain+3.60%
FinancialsBalance sheet and operational figures in Crores
Metric Breakdown

Revenue

Latest (Mar 2020)2882.64 Cr
Growth-27.8%
Revenue Trend (₹ in Crores)
0.02.8k5.6k8.4kSep 2022Mar 2022Mar 2021Mar 2020
PeriodRev (Cr)PAT (Cr)AssetsDebt
Mar 20202,882.648.753,038.2115.13
Mar 20214,894.97-236.54 3,469.751,035.80
Mar 20227,337.02287.863,525.351,134.59
Sep 20223,994.6546.556,461.602,185.52
Key Performance Indicators (KPIs)
PeriodEPSROEROCEP/E (Pre)P/E (Post)
Values06.38%19.03%132.140